The rise of Sildenafil initially fueled a period of growth for major pharmaceutical companies, but recent developments present a uncertain scenario for shareholders. Lower-cost competitors are eroding profits, and https://honeyliil173384.vblogetin.com/47271030/viagra-and-big-pharma-a-volatile-play